Bristol-Myers Squibb Co. (BMY) Tops Q1 EPS by 1c; Sales Light
Tweet
Share
E-mailGet Alerts BMY Hot Sheet
Price: $62.84 -1.19%
EPS Growth %: +5.5%
Financial Fact:
Dividends declared per common share: 0.38
Today's EPS Names:
ALZN, ASPU, USAU, More
EPS Growth %: +5.5%
Financial Fact:
Dividends declared per common share: 0.38
Today's EPS Names:
ALZN, ASPU, USAU, More
Join SI Premium – FREE
Bristol-Myers Squibb Co. (NYSE: BMY) reported Q1 EPS of $0.64, $0.01 better than the analyst estimate of $0.63. Revenue for the quarter came in at $5.25 billion versus the consensus estimate of $5.26 billion.
For earnings history and earnings-related data on Bristol-Myers Squibb Co. (BMY) click here.
For earnings history and earnings-related data on Bristol-Myers Squibb Co. (BMY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- McDonald’s said to plan value strategy overhaul to revive US sales growth
- Faeth Therapeutics adds cancer biologist Karen Vousden to its board
- Buy the pullback in this large pharma stock: UBS
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
